Search Results 1221-1230 of 19920 for Receptor
Has received prior therapy with an anti-programmed cell death 1 receptor (anti-PD-1), antiprogrammed death-ligand 1 (anti-PD-L1), anti-PD-L2, anti-CD137, or ...
Pandey has four patents related to cytokine and immune receptors and development of assays for cancer-specific mutant peptides. He also is the founding ...
New opioid receptor modulators and agonists. Best Pract Res Clin Anaesthesiol. 2018 Jun; 32 (2):125-136 Epub 2018 July 02. View PubMed. PST-20566941. Home ...
... receptor (FcRn) monoclonal antibody with the goal of decreasing TSH receptor antibody levels by 70% to 80%. Enrolled patients will be evaluated jointly by ...
... receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on treatment with ...
Abril participates in clinical trials of new therapies including new medications and cellular therapy such as chimeric antigen receptor (CAR)-T cell therapy.
... receptor antagonist (MRA); LVEF ≥ 45% within previous 12 months. Acceptable methods include echo, ventriculogram (angiography or nuclear), nuclear stress ...
estrogen (E) therapy or treatment with a selective E receptor modulator, or teriparatide (within the past year). Subjects with a fracture within the past ...
Vile's team is combining oncolytic viruses with chimeric antigen receptor T-cell therapy (CAR-T cell therapy) to target solid tumors from liver cancer. This ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.